According to its FDA-approved prescribing information, patients start at a low introductory dose (typically 0.25 mg once weekly), which is not considered to be a therapeutic dose, but it helps the body acclimate to the medication
June 6, 2025: Novo Nordisk Asked to Add NAION, Which Can Cause Blindness, to Ozempic Warning Label The European Medicines Agency has concluded that taking Ozempic and other medications that contain semaglutide may increase someones risk of developing NAION
Staff is so nice and professional I always love coming here
Our team of healthcare professionals is ready to provide personalised guidance and support for all your pharmaceutical needs
Hazama S, Takenouchi H, Tsunedomi R, Iida M, Suzuki N, Iizuka N, et al